![](/wp-content/uploads/2018/10/cZcOGjpNQTqMg4lHvTjo.png)
$599
Lexicon announces additional Ph3 sotagliflozin results in T1DM
Lexicon has announced additional positive data from the Ph3 inTandem1 study. Of note, a slight increase in DKA was seen in the sotagliflozin groups during the extension period with 6 cases (2.5%) on 200mg and 3 cases (1.3%) for 400mg compared to 1 patient (0.4%) on placebo.